aTyr Pharma, Inc. (ATYR)
0.5035
+0.01
(+2.13%)
USD |
NASDAQ |
Sep 03, 16:00
0.5001
0.00 (0.00%)
After-Hours: 06:27
aTyr Pharma Market Cap : 49.39M for Sept. 3, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 03, 2026 | 49.39M |
| September 02, 2026 | 48.36M |
| September 01, 2026 | 46.74M |
| August 31, 2026 | 52.15M |
| August 28, 2026 | 52.97M |
| August 27, 2026 | 54.40M |
| August 26, 2026 | 54.05M |
| August 25, 2026 | 55.91M |
| August 24, 2026 | 51.99M |
| August 21, 2026 | 49.19M |
| August 20, 2026 | 49.34M |
| August 19, 2026 | 52.26M |
| August 18, 2026 | 49.45M |
| August 17, 2026 | 50.90M |
| August 14, 2026 | 54.83M |
| August 13, 2026 | 54.24M |
| August 12, 2026 | 53.00M |
| August 11, 2026 | 52.38M |
| August 10, 2026 | 51.88M |
| August 07, 2026 | 50.16M |
| August 06, 2026 | 49.24M |
| August 05, 2026 | 51.89M |
| August 04, 2026 | 51.89M |
| August 03, 2026 | 48.24M |
| July 31, 2026 | 47.62M |
| Date | Value |
|---|---|
| July 30, 2026 | 47.06M |
| July 29, 2026 | 47.36M |
| July 28, 2026 | 48.44M |
| July 27, 2026 | 48.01M |
| July 24, 2026 | 46.41M |
| July 23, 2026 | 48.84M |
| July 22, 2026 | 47.75M |
| July 21, 2026 | 47.64M |
| July 20, 2026 | 47.69M |
| July 17, 2026 | 49.99M |
| July 16, 2026 | 50.58M |
| July 15, 2026 | 52.39M |
| July 14, 2026 | 47.65M |
| July 13, 2026 | 49.43M |
| July 10, 2026 | 53.38M |
| July 09, 2026 | 57.04M |
| July 08, 2026 | 63.06M |
| July 07, 2026 | 59.43M |
| July 06, 2026 | 64.12M |
| July 02, 2026 | 58.10M |
| July 01, 2026 | 57.83M |
| June 30, 2026 | 58.52M |
| June 29, 2026 | 55.54M |
| June 26, 2026 | 51.72M |
| June 25, 2026 | 54.88M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| MetaVia, Inc. | 12.10M |
| Alnylam Pharmaceuticals, Inc. | 35.37B |
| ACADIA Pharmaceuticals, Inc. | 4.796B |
| Anika Therapeutics, Inc. | 281.04M |
| Savara, Inc. | 1.103B |
Market Cap Related Metrics
| PS Ratio | 259.22 |
| Price to Book Value | 1.012 |
| Price | 0.5035 |
| Earnings Yield | -123.7% |